Market Research Logo

Europe Market for Cerebrospinal Fluid Management 2017 - MedCore

Europe Market for Cerebrospinal Fluid Management 2017 - MedCore

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
The market for CSF management devices includes adjustable and fixed pressure shunts as well as ventricular and lumbar external drainage systems. The market will experience mid-single digit growth over the forecast period, driven primarily by growth in the adjustable pressure shunt market segment. This market segment is also the largest, followed by ventricular drainage systems, fixed pressure shunts and then lumbar drainage systems.

Adjustable pressure shunts are expected to remain the largest segment and are expected to maintain the highest growth. Fixed pressure shunts will remain the second smallest segment and will decline over the forecast period. A declining market will also be seen for the smallest segment, the lumbar drainage system. The ventricular drainage system segment will stay fairly stable with a slight decrease in market value due to competitive pricing.

There is room in this market for substantial innovation as many of the technologies still experience significant complications and novel medical devices to overcome these issues could drive up prices and increase the market value.

Devices in the cerebrospinal fluid (CSF) management market are mainly used for the treatment of hydrocephalus. Hydrocephalus, or “water on the brain,” refers to an abnormal buildup of CSF in the brain’s ventricles. Under normal biological conditions, equilibrium between the production, circulation and absorption of CSF is maintained in the ventricular cavities of the brain as CSF is continually drained away into the circulatory system. Hydrocephalus can result when absorption of fluid into the bloodstream is blocked which leads to an accumulation of CSF. This condition can result in increased intracranial pressure inside of the skull and can lead to tunnel vision, mental disability, progressive enlargement of the head and even death. Symptoms due to the increased intracranial pressure include headaches, nausea, vomiting, papilledema, coma or sleepiness. Further elevation of intracranial pressure can result in uncal and/or cerebellar herniation.


EXECUTIVE SUMMARY
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
PROCEDURES INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics and Neurosurgery
2.2.3 Tumor and Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder
2.2.7.2 Cerebral Edema
2.2.8 Indication for Neuromodulation
2.2.9 Traumatic brain injury
COUNTRY PROFILES
3.1 INTRODUCTION
3.1.1 Population
3.1.2 GDP Per Capita
3.1.3 Price Index
3.2 GERMANY
3.3 FRANCE
3.4 UNITED KINGDOM
3.5 ITALY
3.6 SPAIN
3.7 BENELUX
3.8 SCANDINAVIA
3.9 AUSTRIA
3.10 SWITZERLAND
3.11 PORTUGAL
PRODUCT ASSESSMENT
4.1 PRODUCT PORTFOLIOS
4.1.1 Cerebrospinal Fluid Management
4.1.1.1 Introduction
4.1.1.2 Product Matrix for CFS Management market: Core Companies (1 of 2)
4.1.1.3 Product Matrix for CFS Management market: Core Companies (2 of 2)
4.2 REGULATORY ISSUES AND RECALLS
4.2.1 Cerebrospinal Fluid Management
4.3 CLINICAL TRIALS
4.3.1 Cerebrospinal Fluid Management
CEREBROSPINAL FLUID MANAGEMENT MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Cerebrospinal Fluid Shunt Market
5.3.1.1 Pressure Adjustable Cerebrospinal Fluid Shunt Market
5.3.1.2 Fixed Pressure Cerebrospinal Fluid Shunt Market
5.3.2 Total Cerebrospinal Fluid External Drainage System Market
5.3.2.1 Ventricular Drainage System Market
5.3.2.2 Lumbar Drainage System Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Chart
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023
Chart 3 1: Country Profile, Germany, 2016
Chart 3 2: Country Profile, France, 2016
Chart 3 3: Country Profile, United Kingdom, 2016
Chart 3 4: Country Profile, Italy, 2016
Chart 3 5: Country Profile, Spain, 2016
Chart 3 6: Country Profile, Benelux, 2016
Chart 3 7: Country Profile, Scandinavia, 2016
Chart 3 8: Country Profile, Austria, 2016
Chart 3 9: Country Profile, Switzerland, 2016
Chart 3 10: Country Profile, Portugal, 2016
Chart 5 1: Cerebrospinal Fluid Management Market by Segment, Europe, 2013 – 2023
Chart 5 2: Cerebrospinal Fluid Management Market Breakdown, Europe, 2016
Chart 5 3: Cerebrospinal Fluid Management Market Breakdown, Europe, 2023
Chart 5 4: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2013 – 2023
Chart 5 5: Pressure Adjustable Cerebrospinal Fluid Shunt Market, U.S., 2013 – 2023
Chart 5 6: Fixed Pressure Cerebrospinal Fluid Shunt Market, U.S., 2013 – 2023
Chart 5 7: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2013 – 2023
Chart 5 8: Ventricular Drainage System Market, Europe, 2013 – 2023
Chart 5 9: Lumbar Drainage System Market, Europe, 2013 – 2023
Chart 5 10: Leading Competitors, Cerebrospinal Fluid Management Market, Europe, 2016
List of Figures
Figure 1 1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3)
Figure 1 2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3)
Figure 1 3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3)
Figure 1 4: Companies Researched in this Report, Europe, 2016
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3)
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3)
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3)
Figure 1 8: Recent Events in the Neurological Device Market, Europe, 2014 – 2016
Figure 1 9: Neurological Device Markets Covered, Europe, 2016
Figure 1 10: Neurological Device Procedures Covered, Europe, 2016
Figure 1 11: Key Report Updates
Figure 1 12: Version History
Figure 2 1: Neurology Disease Overview
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
Figure 4 1: Shunt Types
Figure 4 2: Class 2 Device Recall: VentriClear II Ventricular Drainage Catheter Set, Cook Inc.
Figure 4 3: Class 2 Device Recall: Aesculap Miethke Shunt System
Figure 4 4: Class 2 Device Recall: Aesculap Miethke Shunt System, miniNAV Valve
Figure 4 5: Class 2 Device Recall: Codman
Figure 4 6: Class 2 Device Recall: Codman Cetras
Figure 4 7: Class 2 Device Recall: Medtronic Duet External Drainage and Monitoring System
Figure 4 8: Class 2 Device Recall: Aesculap Inc. (AIC) Miethke Ventricular Catheter with Deflector/Miethke Shunt System
Figure 4 9: Class 2 Device Recall: Aesculap
Figure 4 10: Class 2 Device Recall: Integra Cranial Access Kit
Figure 4 11: Class 2 Device Recall: Integra Cranial Access Kit
Figure 4 12: Class 2 Device Recall: CSFUnitized Shunt, Medtronic
Figure 4 13: Class 2 Device Recall: Aesculap(R) Miethke Shunt System
Figure 4 14: Class 2 Device Recall: Pudenz Flushing Valve
Figure 4 15: CSF Management: Strata Programmable CSF Shunt Valve Study
Figure 4 16: CSF Management: Cerebrospinal Fluid (CSF) Drainage Study
Figure 4 17: CSF Management: Lumbar Drainage in Subarachnoid Haemorrhage (LUMAS)
Figure 5 1: Cerebrospinal Fluid Management Market by Segment, Europe, 2013 – 2023 (€M)
Figure 5 2: Cerebrospinal Fluid Management Market by Segment, Europe, 2013 – 2023 (US$M)
Figure 5 3: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2013 – 2023 (€M)
Figure 5 4: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2013 – 2023 (US$M)
Figure 5 5: Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 6: Units Sold by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023
Figure 5 7: Average Selling Price by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€)
Figure 5 8: Average Selling Price by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$)
Figure 5 9: Market Value by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€M)
Figure 5 10: Market Value by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$M)
Figure 5 11: Fixed Pressure Cerebrospinal Fluid Shunt Market, U.S., 2013 – 2023 (€ and US$)
Figure 5 12: Units Sold by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023
Figure 5 13: Average Selling Price by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€)
Figure 5 14: Average Selling Price by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$)
Figure 5 15: Market Value by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€M)
Figure 5 16: Market Value by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$M)
Figure 5 17: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2013 – 2023 (€M)
Figure 5 18: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2013 – 2023 (US$M)
Figure 5 19: Ventricular Drainage System Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 20: Units Sold by Country, Ventricular Drainage System Market, Europe, 2013 – 2023
Figure 5 21: Average Selling Price by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (€)
Figure 5 22: Average Selling Price by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (US$)
Figure 5 23: Market Value by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (€M)
Figure 5 24: Market Value by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (US$M)
Figure 5 25: Lumbar Drainage System Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 26: Units Sold by Country, Lumbar Drainage System Market, Europe, 2013 – 2023
Figure 5 27: Average Selling Price by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (€)
Figure 5 28: Average Selling Price by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (US$)
Figure 5 29: Market Value by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (€M)
Figure 5 30: Market Value by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (US$M)
Figure 5 31: Drivers and Limiters, Cerebrospinal Fluid Management Market, Europe, 2016
Figure 5 32: Leading Competitors, Cerebrospinal Fluid Management Market, Europe, 2016
Figure 7 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report